Neuphoria Therapeutics, Inc. (NEUP)
3.73
0.00 (0.00%)
USD |
NASDAQ |
Sep 11, 16:00
3.74
+0.01
(+0.27%)
After-Hours: 20:00
Neuphoria Therapeutics Net Income (Quarterly) : -0.5051M for March 31, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.5051M |
| December 31, 2025 | 1.864M |
| September 30, 2025 | -9.906M |
| March 31, 2025 | 11.26M |
| December 31, 2024 | -1.943M |
| Date | Value |
|---|---|
| September 30, 2024 | -0.8048M |
| June 30, 2024 | -2.687M |
| March 31, 2024 | -2.778M |
| December 31, 2023 | -4.554M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| Anika Therapeutics, Inc. | 3.309M |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
| Imunon, Inc. | -2.814M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.5051M |
| EPS Diluted (Quarterly) | -0.0933 |
| Enterprise Value | 0.6508M |
| Earnings Yield | 34.12% |
| Operating Earnings Yield | 17.96% |
| Normalized Earnings Yield | 62.77 |